| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/06/2005 | EP1549387A1 Antisense modulation of farnesoid x receptor expression |
| 07/06/2005 | EP1549358A1 Composition for filling bone defects |
| 07/06/2005 | EP1549352A2 Methods for delivery of nucleic acids |
| 07/06/2005 | EP1549351A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/06/2005 | EP1549346A2 Amended recombinant cells (arcs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants |
| 07/06/2005 | EP1549341A2 Novel tissue factor targeted antibodies as anticoagulants |
| 07/06/2005 | EP1549337A1 Glycosaminoglycan-dnase combination therapy |
| 07/06/2005 | EP1549336A2 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 07/06/2005 | EP1549335A1 A method of modulating cellular activity and molecules for use therein |
| 07/06/2005 | EP1549334A1 A pharmaceutical composition comprising a retro-iverso isomer pettide |
| 07/06/2005 | EP1549333A1 Compstatin analogs with improved activity |
| 07/06/2005 | EP1549332A2 Modified asialo-interferons and uses thereof |
| 07/06/2005 | EP1549311A1 Potent inhibitor of hcv serine protease |
| 07/06/2005 | EP1549290A1 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| 07/06/2005 | EP1549289A1 Effervescent formulations of oxytocin |
| 07/06/2005 | EP1549277A1 Induction and maintenance of tolerance to composite tissue allografts |
| 07/06/2005 | EP1549246A2 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 07/06/2005 | EP1549198A2 Thymic atrophy |
| 07/06/2005 | EP1549140A2 Production of peptides in plants as viral coat protein fusions |
| 07/06/2005 | EP1450845A4 15603, a human ion channel family member |
| 07/06/2005 | EP1330254B1 Treatment of cancers by aplidine in conjunction with carnitine or acetylcarnitine |
| 07/06/2005 | EP1230375B1 Inhibiting gene expression with dsrna |
| 07/06/2005 | EP1171089B1 Skin care compositions containing combination of skin care actives |
| 07/06/2005 | EP1140909B1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2005 | EP1140145B1 Novel exendin agonist formulations and methods of administration thereof |
| 07/06/2005 | EP1071442B1 Methods and compositions for peptide synthesis (t-20) |
| 07/06/2005 | EP0937461B1 Use of proteins from the mk family as hematopoietic factor |
| 07/06/2005 | EP0870032B1 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 07/06/2005 | EP0730651B1 Surface loop structural analogues of fibroblast growth factors |
| 07/06/2005 | CN1636070A Nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636063A Genetic vaccine against human immunodeficiency virus |
| 07/06/2005 | CN1636060A Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 07/06/2005 | CN1636059A Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2 |
| 07/06/2005 | CN1636058A Novel alanine transaminase enzyme and methods of use |
| 07/06/2005 | CN1636056A Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 07/06/2005 | CN1636050A Core-glycosylated HCV envelope proteins |
| 07/06/2005 | CN1636017A Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 07/06/2005 | CN1636016A Methods to inhibit viral replication |
| 07/06/2005 | CN1636014A Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects |
| 07/06/2005 | CN1636012A Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 07/06/2005 | CN1636010A Compositions for DNA mediated gene silencing |
| 07/06/2005 | CN1635988A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/06/2005 | CN1635913A A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide T |
| 07/06/2005 | CN1635912A Targeted delivery of drugs for the treatment of parasitic infections |
| 07/06/2005 | CN1635907A Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 07/06/2005 | CN1635902A Remedy for infections |
| 07/06/2005 | CN1635901A Remodeling and glycoconjugation of peptides |
| 07/06/2005 | CN1635900A Pre-mixes of GLP-1 and basal insulin |
| 07/06/2005 | CN1635899A Stimulation of bone growth with thrombin peptide derivatives |
| 07/06/2005 | CN1635898A Super-active porcine growth hormone releasing hormone analog |
| 07/06/2005 | CN1635896A Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 07/06/2005 | CN1635886A Method for treating diseases with omega interferon |
| 07/06/2005 | CN1635878A Methods of treating cancer and the pain associated therewith with using endothelin antagonists |
| 07/06/2005 | CN1635874A Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 07/06/2005 | CN1635858A Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same |
| 07/06/2005 | CN1635849A Bone anti-resorptive compounds |
| 07/06/2005 | CN1635832A Method for administering GLP-1 molecules |
| 07/06/2005 | CN1635119A Process for preparing amyloidosis polypeptide beta (Abeta), a senile dementia causing substance, and product yield thereof |
| 07/06/2005 | CN1634995A Arginine deacylase fusion protein, method for preparation and application |
| 07/06/2005 | CN1634993A Recombined human interferon-alpha 1b compound and process for preparation |
| 07/06/2005 | CN1634987A Spleen polypeptide extract, its preparing process and use |
| 07/06/2005 | CN1634986A A novel Kunin type polypeptide and method for making same |
| 07/06/2005 | CN1634985A Pig Ghrelin derivative, its encoding gene and application |
| 07/06/2005 | CN1634981A A plurality of antibiotic peptides, method for preparation and use thereof |
| 07/06/2005 | CN1634979A Ligand of NKG2D acceptor and use |
| 07/06/2005 | CN1634978A SARS virus HLA-A2 limited epitope polypeptide and uses thereof |
| 07/06/2005 | CN1634976A Process for preparing nano active compound by extracting maize germ and product made therefrom |
| 07/06/2005 | CN1634962A Process for preparing synergy factor in artificial blood, nucleotide sequence used thereby |
| 07/06/2005 | CN1634596A Gene engineering vaccine used for preventing pig cysticercosis and its preparation method |
| 07/06/2005 | CN1634577A Cinobufotalin lyophilized powder for injection and its preparation method |
| 07/06/2005 | CN1634576A Medicine composition for improving stability of human urine kininogenase |
| 07/06/2005 | CN1634575A Application of human urine kininogenase for preparing medicine to treat acute coronary syndromes |
| 07/06/2005 | CN1634574A Use of human lysozyme for preparing medicine to treat intertrigo |
| 07/06/2005 | CN1634573A Use of human lysozyme for preparing medicine to treat prickly heat |
| 07/06/2005 | CN1634572A Biological collagen injection as substituted blood plasma and its preparation method |
| 07/06/2005 | CN1634571A Interferon vaginal effervescent tablet and its preparation method |
| 07/06/2005 | CN1634570A Method for preparing interferon long-acting injection microsphere preparation |
| 07/06/2005 | CN1634569A Animal interferon gene engineering biologically active preparation |
| 07/06/2005 | CN1634568A Use of biological keratin for pharmaceutical preparation |
| 07/06/2005 | CN1634567A Process and formula for preparing gelling agent containing alkalic fibroblast growth factor |
| 07/06/2005 | CN1634566A Thymosin peptide oral tablet and its preparation method |
| 07/06/2005 | CN1634565A Protein medicine microcapsule and inhalational aerosol thereof |
| 07/06/2005 | CN1634564A Preparation and use of mannan peptide oral granule |
| 07/06/2005 | CN1634563A Spray for treating burn |
| 07/06/2005 | CN1634562A Medicine for treating fungal dermatitis |
| 07/06/2005 | CN1634561A Medicine for treating oral ulcer |
| 07/06/2005 | CN1634560A Medicine for treating bronchial asthma |
| 07/06/2005 | CN1634559A Medicine for relieving drunk |
| 07/06/2005 | CN1634558A Medicine for treating Parkinson's disease |
| 07/06/2005 | CN1634557A Medicine for treating ulcerative colitis |
| 07/06/2005 | CN1634556A Medicine for treating peptic ulcer |
| 07/06/2005 | CN1634555A Medicine for treating chronic gastritis |
| 07/06/2005 | CN1634554A Reduced glutathione soft capsule and manufacturing process thereof |
| 07/06/2005 | CN1634553A Reduced glutathione soft capsule and manufacturing process thereof |
| 07/06/2005 | CN1634552A Compound cerebroprotein hydrolysate medicine preparation and method for preparing the same |
| 07/06/2005 | CN1634551A Compound piracetam and cerebroprotein hydrolysate medicine preparation and method for preparing the same |
| 07/06/2005 | CN1633889A Liver protecting health food |
| 07/06/2005 | CN1209373C Human protein with suppression to cancer cell growth and its coding sequence |